1型糖尿病中冠状动脉钙化与随后心血管疾病发生率的关联:DCCT/EDIC试验
在DCCT/EDIC队列1205名1型糖尿病参与者中,于平均42.8岁时行CT测量冠状动脉钙化(CAC)评分,随访10至13年分析其与后续心血管疾病(CVD)及主要不良心脏事件(MACE)的关系;CAC>100至300和>300 Agatston单位与CVD和MACE风险升高显著相关,而CAC>0至100仅名义上与CVD相关。
要点
- CAC评分0分者占70.7%,其CVD事件率很低(5.6/1000人年)。
- CAC>100至300与CVD风险升高相关(HR 4.17),>300者HR 6.06。
- CAC>100至300与MACE风险升高相关(HR 5.40),>300者HR 6.91。
核心结论
- 在DCCT/EDIC队列中,CAC评分>100 Agatston单位与1型糖尿病患者随后发生CVD和MACE的风险显著增加相关。
研究设计与样本
- 研究为DCCT/EDIC试验队列分析,在EDIC第7至9年、DCCT结束后对1205名参与者行CT测量CAC,平均年龄42.8岁,随访10至13年观察首次CVD事件或首次MACE。
诊断标准与关键数值
- CAC按Agatston单位分为0、>0至100、>100至300、>300四组;以CAC=0为参照,CAC>100至300与CVD的HR为4.17、与MACE的HR为5.40,CAC>300与CVD的HR为6.06、与MACE的HR为6.91(p<0.0001);CAC>0至100与CVD的HR为1.71(p=0.0415)、与MACE的HR为1.11(p=0.8134)。
临床应用与阅片要点
- 在1型糖尿病患者中,CAC评分>100 Agatston单位提示后续CVD和MACE风险显著升高;CAC=0者事件率很低;CAC对AUC的增量有限。
局限性
- CAC对AUC的增量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to determine the relationship between coronary artery calcium (CAC) scores and subsequent cardiovascular disease (CVD) events in DCCT (Diabetes Control and Complications Trial)/EDIC (Epidemiology of Diabetes Interventions and Complications) participants.
BACKGROUND: The CAC score has been validated for improved risk stratification in general populations; however, this association has not been well studied in type 1 diabetes (T1DM).
METHODS: Computed tomography (CT) to measure CAC was performed in 1,205 DCCT/EDIC participants at a mean of 42.8 years of age during EDIC years 7 to 9, after the end of DCCT. This study analyzed the association between CAC and time to the first subsequent CVD event or to the first major adverse cardiac event (MACE), a follow-up of 10 to 13 years. CAC was categorized as: 0, >0 to 100, >100 to 300, or >300 Agatston units.
RESULTS: Of 1,156 participants at risk for subsequent CVD, 105 had an initial CVD event (8.5 per 1,000 patient-years); and of 1,187 participants at risk for MACE, 51 had an initial MACE event (3.9 per 1,000 patient-years). Event rates among those with scores of zero (n = 817 [70.7%]) were very low for CVD (5.6 per 1,000 patient years). CAC scores >100 to 300 (hazard ratio [HR]: 4.17, 5.40) and >300 (HR: 6.06, 6.91) were associated with higher risks of CVD and MACE, respectively, compared to CAC of 0 (p < 0.0001). CAC scores >0 to 100 were nominally associated with CVD (HR: 1.71; p = 0.0415) but not with MACE (HR: 1.11; p = 0.8134). Similar results were observed when also adjusted for mean HbA1c and conventional CVD risk factors. The increment in the AUC due to CAC was modest.
CONCLUSIONS: CAC scores >100 Agatston units were significantly associated with an increased risk of the subsequent occurrence of CVD and MACE in DCCT/EDIC cohort. (Diabetes Control and Complications Trial [DCCT]; NCT00360815; Epidemiology of Diabetes Interventions and Complications [EDIC]; NCT00360893).
引用
- Budoff M, Backlund JC, Bluemke DA, et al. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials. JACC Cardiovasc Imaging. 2019. PMID: 30878435. doi:10.1016/j.jcmg.2019.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。